Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
Go back to Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity| (NASDAQ: CRBP) | Delayed: 7.48 +0.22 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.26 | 52 Week High | $10.78 | |||
| Open | $7.22 | 52 Week Low | $1.01 | |||
| Day High | $7.67 | P/E | N/A | |||
| Day Low | $7.15 | EPS | $0.00 | |||
| Volume | 1,155,047 | |||||
